GRIM-19 Restores Cervical Cancer Cell Senescence by Repressing Htert Transcription.

Ying Zhou,Fei Xu,Feng Tao,Dingqing Feng,Bin Ling,Lili Qian,Xia Yang,Qingyuan Wang,Huiyan Wang,Weidong Zhao,Yong Cheng,Ge Shan,Dhan V. Kalvakolanu,Weihua Xiao
DOI: https://doi.org/10.1089/jir.2015.0125
2016-01-01
Journal of Interferon & Cytokine Research
Abstract:High telomerase activity promotes tumor growth by stabilizing damaged chromosomes and their mitotic replication. Overactivation of telomerase activity has been reported in cervical cancer, a malignancy caused by high-risk human papillomaviruses (HR-HPVs). The HR-HPV E6 can activate hTERT promoter by interacting with E6AP or other binding proteins and by stabilizing the interaction between hTERT and E6AP. GRIM-19 is a novel tumor suppressor that affects multiple targets in a cell to regulate growth. We have previously reported the interaction of GRIM-19 with 18E6 and E6AP to disrupt the E6/E6AP complex and increase the autoubiquitination of E6AP. In this study, we characterized the interaction of GRIM-19 with 16E6 (an oncoprotein produced by HPV16) and identified the binding sites that mediate this interaction. We also found that GRIM-19 expression in cervical cancer cells could inhibit telomerase activity by inhibiting the transactivation of the hTERT promoter by E6, thereby promoting cervical cancer cell senescence. Moreover, we identified a negative correlation between GRIM-19 and hTERT expression in cervical cancer tissues. Suppression of GRIM-19 and induction of hTERT levels were associated with lymph node metastasis, advanced clinical stage, and poor prognosis. This study identified another important novel antitumor molecular link associated with GRIM-19 in the tumorigenesis.
What problem does this paper attempt to address?